Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ANGIODYNAMICS INC (ANGO)

$13.59 +1.12% NASDAQ: ANGO · 15-min delayed
  • LATHAM, New York
  • Public · NASDAQ: ANGO
  • 675 employees
$493.3MMarket cap
$292.5MRevenue · FY2025
-$34.0MNet income
675Employees
ANGONASDAQ
2004IPO

About ANGIODYNAMICS INC

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$292.5M
Net income
-$34.0M
Total assets
$280.1M
Market cap
$493.3M
Gross margin
54.6%
Operating margin
-12.5%
Net margin
-11.5%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2026

Financial statements

Income statement

Revenue
$320.2M
Cost of revenue
$145.3M
Gross profit
$174.9M
Operating expenses
$214.8M
Operating income
-$39.9M
Income tax
$442.0K
Net income
-$36.7M
EPS (basic)
$-0.88
EPS (diluted)
$-0.88

Balance sheet

Total assets
$267.2M
Current assets
$163.4M
Total liabilities
$96.3M
Current liabilities
$74.7M
Shareholders’ equity
$170.8M

Cash flow

Operating cash flow
$3.1M
Investing cash flow
-$5.9M
Financing cash flow
$564.0K
Net cash flow
-$2.0M

Statements via Polygon.io (SEC filings)

NASDAQ: ANGO
$13.59 +1.12%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$8.40 $14.47

52-week range

Market cap
$493.3M
EPS (diluted)
$-0.88
Shares outstanding
36.3M
Open
Day range
Prev close
Volume
IPO date
May 27, 2004

Angiodynamics Inc (ANGO) Stock Price

  • Reported a net loss of $34.0M in FY2025.
  • Revenue grew 1% from FY2022 to FY2026.
  • Gross margin of 54.6%, net margin -11.5%.
  • Trading 6% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review ANGIODYNAMICS INC.

Write a review
Newsroom

News about ANGIODYNAMICS INC

News & sentiment via Polygon.io

FAQ

Angiodynamics Inc: frequently asked questions

Is Angiodynamics Inc an American company?

Angiodynamics Inc is a US-based company headquartered in Latham, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Angiodynamics Inc headquartered?

Angiodynamics Inc is headquartered in Latham, New York, United States.

Is Angiodynamics Inc publicly traded?

Yes — Angiodynamics Inc is a publicly traded company. Its stock trades under the ticker symbol ANGO on the NASDAQ.

What does Angiodynamics Inc do?

Angiodynamics Inc is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →